Cure My Disease

Don't miss your cure!

 Log in / Sign up

Revolutionary cell therapy tested for devastating autoimmune diseases

NCT ID NCT07048197

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This early-stage trial is testing a new CAR-T cell therapy called rapcabtagene autoleucel for people with severe rheumatoid arthritis and Sjogren's disease that hasn't responded to standard treatments. The study will primarily check if the treatment is safe and how the modified cells behave in the body, while also looking for early signs that it might help control these difficult autoimmune conditions. It involves 27 adult participants whose diseases remain active despite trying other available therapies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) AND SJÖGREN'S DISEASE (SJD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Novartis Investigative Site

    RECRUITING

    Bordeaux, 33076, France

  • Novartis Investigative Site

    RECRUITING

    Brest, 29200, France

  • Novartis Investigative Site

    RECRUITING

    Le Kremlin-Bicêtre, 94275, France

  • Novartis Investigative Site

    RECRUITING

    Lille, 59037, France

  • Novartis Investigative Site

    RECRUITING

    Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany

  • Novartis Investigative Site

    RECRUITING

    Cologne, North Rhine-Westphalia, 50937, Germany

  • Novartis Investigative Site

    RECRUITING

    Berlin, 13353, Germany

  • Novartis Investigative Site

    RECRUITING

    Ulm, 89081, Germany

  • Novartis Investigative Site

    RECRUITING

    Singapore, 119074, Singapore

  • Novartis Investigative Site

    RECRUITING

    Barcelona, 08035, Spain

  • Novartis Investigative Site

    RECRUITING

    Madrid, 28034, Spain

Conditions

Explore the condition pages connected to this study.

RHEUMATOID ARTHRITIS (RA) AND SJÖGREN'S DISEASE (SJD)